Patents by Inventor Zejuan Sheng

Zejuan Sheng has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USES OF PHOSPHODIESTERASE INHIBITORS
    Publication number: 20220160696
    Abstract: Disclosed are uses of a compound represented by general formula (I) and pharmaceutically acceptable salts, isomers and deuterated compounds thereof in the preparation of a medicine for treating heart failure diseases. Experiments prove that the compound can improve the heart function of rats with heart failure, reverse myocardial remodeling caused by heart failure, and reduce fibrosis in the marginal zone of infarction.
    Type: Application
    Filed: March 6, 2020
    Publication date: May 26, 2022
    Applicant: TRANSTHERA SCIENCES (NANJING), INC.
    Inventors: Zejuan SHENG, Frank Wu
  • ASSAYS AND BIOMARKERS FOR LRRK2
    Publication number: 20140228384
    Abstract: Biomarkers for screening subjects for Parkinson's disease and providing companion diagnostic tools for therapies using LRRK2 modulators, and assays for screening compounds and compositions for modulation of LRRK2 activity.
    Type: Application
    Filed: May 29, 2013
    Publication date: August 14, 2014
    Inventors: Daisy Bustos, Donald Kirkpatrick, Tracy Kleinheinz, John Moffat, Zejuan Sheng, Shuo Zhang, Haitao Zhu